For Public Review and Comments. Stakeholder's may provide comments within 45 days of upload of the monographs to This email address is being protected from spambots. You need JavaScript enabled to view it..

 

 Acetylcysteine (Ver. 1) (11.09.2023)

 Adapalene Gel (Ver. 1) (11.09.2023)

 Adapalene (Ver. 1) (11.09.2023)

 Cefprozil (Ver. 1) (11.09.2023)

 Clarithromycin Oral Suspension (Ver. 1) (11.09.2023)

 Clarithromycin Prolonged-release Tablets (Ver. 1) (11.09.2023)

 Clindamycin Gel (Ver. 1) (11.09.2023)

 Dapagliflozin and Sitagliptin Tablets (Ver. 1) (11.09.2023)

 Dapagliflozin Propanediol Monohydrate (Ver. 1) (11.09.2023)

 Dapagliflozin Tablets (Ver. 1) (11.09.2023)

 Vildagliptin and Metformin Prolonged-release Tablets (Ver. 1) (11.09.2023)

 

 Bepotastine Tablets (Ver. 1) (18.01.2024)

 Bepotastine Besilate (Ver. 1) (18.01.2024)

 Ciprofloxacin for Oral Suspension (Ver. 1) (18.01.2024)

 Dibasic Calcium Phosphate Dihydrate (Ver. 1) (18.01.2024)

 Dihydroergotamine Injection (Ver. 1) (18.01.2024)

 Edetate Calcium Disodium (Ver. 1) (18.01.2024)

 Nitrofurantoin Oral Suspension (Ver. 1) (18.01.2024) 

 Nitrofurazone Ointment (Ver. 1) (18.01.2024)

 Tramadol Tablets (Ver. 1) (18.01.2024)

 Tricholine Citrate (Ver. 1) (18.01.2024)

 

 Calcium Polystyrene Sulphonate (Ver. 1) (01.08.2024)

Desloratadine (Ver. 1) (01.08.2024)

Desloratadine Tablets (Ver. 1) (01.08.2024) 

Galantamine Tablets (Ver. 1) (01.08.2024) 

Levetiracetam Injection (Ver. 1) (01.08.2024) 

Oxytocin Concentrated Solution (Ver. 1) (01.08.2024)

Pomalidomide (Ver. 1) (01.08.2024)

Pomalidomide Capsules (Ver. 1) (01.08.2024)

Sodium Polystyrene Sulphonate (Ver. 1) (01.08.2024)

Sodium Stearyl Fumarate (Ver. 1) (01.08.2024)

Sunitinib Malate (Ver. 1) (01.08.2024)

Sunitinib Capsules (Ver. 1) (01.08.2024)

Xylitol (Ver. 1) (01.08.2024)

 

Acamprosate Gastro-resistant Tablets (Ver. 2) (01.08.2024)

Acetylcysteine Injection (Ver. 2) (01.08.2024)

Adenine (Ver. 2) (01.08.2024)

Aluminium Sulphate (Ver. 2) (01.08.2024)

Amantadine Tablets (Ver. 2) (01.08.2024)

Calcium Folinate Tablets (Ver. 2) (01.08.2024)

Carbamazepine Oral Suspension (Ver. 2) (01.08.2024)

Cefprozil Tablets (Ver. 2) (01.08.2024)

Cefuroxime Axetil Oral Suspension (Ver. 2) (01.08.2024)

Celecoxib Capsules (Ver. 2) (01.08.2024)

Clindamycin Tablets (Ver. 2) (01.08.2024)

Copper Sulphate (Ver. 2) (01.08.2024)

Dapagliflozin (Ver. 2) (01.08.2024)

Entecavir Oral Solution (Ver. 2) (01.08.2024)

Ferric Carboxymaltose (Ver. 2) (01.08.2024)

Ferric Carboxymaltose Injection (Ver. 2) (01.08.2024)

Fulvestrant Injection (Ver. 2) (01.08.2024)

Frusemide Oral Solution (Ver. 2) (01.08.2024)

Isoniazid Oral Solution (Ver. 2) (01.08.2024)

Itraconazole Oral Solution (Ver. 2) (01.08.2024)

Minocycline Hydrochloride (Ver. 2) (01.08.2024)

Minocycline Capsules (Ver. 2) (01.08.2024)

Minocycline Tablets (Ver. 2) (01.08.2024)

Minocycline Injection (Ver. 2) (01.08.2024)

Paracetamol and Mefenamic Acid Suspension (Ver. 2) (01.08.2024)

Paracetamol and Mefenamic Acid Tablets (Ver. 2) (01.08.2024)

Pilocarpine Hydrochloride (Ver. 2) (01.08.2024)

Pilocarpine Hydrochloride Eye Drops (Ver. 2) (01.08.2024)

Phytomenadione Tablets (Ver. 2) (01.08.2024)

Sildenafil Injection (Ver. 2) (01.08.2024)

Tramadol Injection (Ver. 2) (01.08.2024)

News & Highlights


View All
 

nfi

IPC Products

ip nfi
 
Connect with IPC